Metraipolis › archive › dc_48aa42efaec5

Hydrocortisone use in France: current practices in 2026 — Europe PMC PMID:42418052

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42418052
DOI
10.1007/s00431-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-18T10:17:24.343Z
SHA-256 of the archived text
2c79f5d4b20f4928df1c8034684f4d36a88751f04a4bf7c636110aad543f9d52
Stable URL of this page
https://metraipolis.com/documento/dc_48aa42efaec5

How to cite

Hydrocortisone use in France: current practices in 2026 — Europe PMC PMID:42418052 — Europe PMC (en), https://europepmc.org/article/MED/42418052 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48aa42efaec5 (Metraipolis archive dc_48aa42efaec5, sha256 2c79f5d4b20f4928df1c8034684f4d36a88751f04a4bf7c636110aad543f9d52)
BibTeX
@misc{dc48aa42efaec5,
  title = {Hydrocortisone use in France: current practices in 2026 — Europe PMC PMID:42418052},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42418052},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48aa42efaec5; sha256 2c79f5d4b20f4928df1c8034684f4d36a88751f04a4bf7c636110aad543f9d52},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42418052. Agents can read the archived copy with the MCP tool read_document.